ADVB Advanced Biomed Inc.

6.210USD-2.66%Mkt Cap: 10.26M $P/E: 1.28

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include …

Key Statistics

Company
Market Cap10.26M USD
Enterprise Value6.92M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)4.76M USD
Revenue/Share—
Last Price6.210 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees31
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)1.28
P/E (Forward)—
PEG—
EV/EBITDA-2.35
EV/Revenue—
P/S—
P/B0.96
EPS (TTM)4.85
EPS (Forward)—
52W Range
3.61013% of range24.23
52W High24.23 USD
52W Low3.610 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE71.33%
ROA-21.50%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.13M USD
CapEx (TTM)74.11K USD
FCF Margin—
FCF Yield-82.74%
Net Debt-1.90M USD
Net Debt/EBITDA0.65
Balance Sheet
Debt/Equity7.74
Current Ratio7.38
Quick Ratio1.90
Book Value/Sh6.66 USD
Cash/Share1.89 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateFeb 20, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.65M
Float632.39K
Insiders55.36%
Institutions1.34%
Short Interest
Short Ratio0.1d
Short % Float1.13%
Short % Out.0.60%
Shares Short9.85K
Short (prev mo.)37.36K
Technical
SMA 508.226 (-24.5%)
SMA 2006.181 (+0.5%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)93.36K
Avg Vol (10d)18.56K
Technical Indicators
RSI (14)38.9
MACD-0.5363
MACD Signal-0.5352
MACD Hist.-0.0011
BB Upper8.494 USD
BB Middle6.910 USD
BB Lower5.325 USD
BB Width45.86%
ATR (14)0.7227 USD
Vol Ratio (20d)0.69x